|
NOL10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.30630000000298E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.613500E-04 |
| Normal-vs-Stage2 |
1.105860E-02 |
| Normal-vs-Stage3 |
2.019800E-04 |
| Normal-vs-Stage4 |
2.661200E-03 |
| Stage1-vs-Stage2 |
5.438400E-01 |
| Stage1-vs-Stage3 |
2.175000E-01 |
| Stage1-vs-Stage4 |
5.789800E-01 |
| Stage2-vs-Stage3 |
7.945400E-01 |
| Stage2-vs-Stage4 |
9.069200E-01 |
| Stage3-vs-Stage4 |
6.484000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.633000E-04 |
| Normal-vs-AfricanAmerican |
7.01909996791983E-09 |
| Normal-vs-Asian |
3.507000E-01 |
| Caucasian-vs-AfricanAmerican |
1.197740E-04 |
| Caucasian-vs-Asian |
7.640600E-01 |
| AfricanAmerican-vs-Asian |
5.543500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5989000000014E-05 |
| Normal-vs-Female |
2.923100E-03 |
| Male-vs-Female |
2.364800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.078200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.004900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.173900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.538400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.301800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.522000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.856600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.037800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.465000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.664800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.253800E-01 |
| Normal-vs-Grade 2 |
4.581600E-03 |
| Normal-vs-Grade 3 |
2.20439999999433E-05 |
| Normal-vs-Grade 4 |
7.260700E-03 |
| Grade 1-vs-Grade 2 |
5.946000E-01 |
| Grade 1-vs-Grade 3 |
1.706840E-01 |
| Grade 1-vs-Grade 4 |
4.286800E-01 |
| Grade 2-vs-Grade 3 |
4.095600E-02 |
| Grade 2-vs-Grade 4 |
5.756000E-01 |
| Grade 3-vs-Grade 4 |
3.585800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.810040E-01 |
| Normal-vs-ccB subtype |
1.60738999999133E-05 |
| ccA subtype-vs-ccB subtype |
2.387800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.388300E-04 |
| Normal-vs-N1 |
7.196000E-01 |
| N0-vs-N1 |
2.642000E-01 |
|
|
